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INTRODUCTION
Rhinitis and rhinoconjunctivitis are common diseases world-
wide in both adults and children, and their prevalence appears 
to be increasing.1 There are wide variations in the prevalence of 
rhinitis and rhinoconjunctivitis in different countries and in dif-
ferent regions within the same country.2 Furthermore, ocular 
symptoms are common and contribute to the burden of rhinitis.3
Ocular allergic symptoms are strongly associated with allergic 
rhinitis, even though they are often underdiagnosed–at least in 
mild forms–and consequently undertreated. Conjunctivitis is 
now increasingly recognized as a distinct disorder that imposes 
its own burden on both medical costs and a patient’s quality of 
life (QoL).4
Rhinitis and conjunctivitis can be associated with other in-
flammatory diseases, such as asthma.4 The link between the 
upper and the lower respiratory tracts (united airway disease) 
has been established previously5; in this context, conjunctivitis 
should be considered part of this entity because the allergic re-
sponse involves the conjunctival surface as well as the respira-
tory tract.2 Consequently, the Allergic Rhinitis and its Impact on 
Asthma (ARIA) initiative has now recognized conjunctivitis as a 
frequent comorbidity of allergic rhinitis.6 Moreover, although 
The Burden of Rhinitis and Rhinoconjunctivitis in Adolescents
Fabio Cibella,* Giuliana Ferrante, Giuseppina Cuttitta, Salvatore Bucchieri, Mario R Melis, Stefania La Grutta, Giovanni Viegi
National Research Council of Italy, Institute of Biomedicine and Molecular Immunology, Palermo, Italy
rhinitis is a well-recognized risk factor for asthma and is associ-
ated with increased asthma severity,7 little is known on the role 
of conjunctivitis as an additional risk factor.
Few studies have explored the impact of allergic conjunctivitis 
on asthma.3 Therefore, using a population sample evaluated 
during a cross-sectional study performed on schoolchildren, 
we investigated (1) whether rhinitis and rhinoconjunctivitis are 
associated with different risk factors, (2) the impact of rhinitis 
and rhinoconjunctivitis on asthma, and (3) the burden of rhi-
noconjunctivitis among adolescents.
MATERIALS AND METHODS
Study design
This is a cross-sectional study conducted on a random sample 
of schoolchildren, aged 10-17 years, living in the city of Palermo 
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in the Mediterranean area of Southern Italy, between Novem-
ber 2005 and May 2006.8 Students completed a questionnaire 
based on SIDRIA and ISAAC surveys9,10 and underwent skin 
prick tests (SPTs) at school. A total of 2,150 children were evalu-
ated. The study was approved by the Institutional Ethics Com-
mittee. All parents of invited adolescents signed a written in-
formed consent. According to Italian law, individual privacy 
was respected.
Questionnaire
The self-administered questionnaire was completed by ado-
lescents at school regarding respiratory allergic symptoms, dis-
eases and personal information.9 The core questionnaire mod-
ules of ISAAC for 13-14 year olds for wheezing and rhinitis were 
used.11 According to ISAAC methods,11 a child’s history of asth-
ma  was defined as a positive answer to the question “Have you 
ever had asthma? ”; Rhinitis was defined as a positive answer to 
the question “Have you ever had a problem with sneezing, or 
runny, or blocked nose apart from common cold or flu in the last 
12 months? ”; Conjunctivitis was defined by the question “In the 
past 12 months, has this nose problem been accompanied by 
itching and/or watering eyes? ”. Based on these criteria, we iden-
tified the following subgroups: subjects with asthma, subjects 
with rhinitis, subjects with rhinoconjunctivitis, and asymptom-
atic children without asthma or rhinoconjunctivitis. Current 
asthma was defined as asthma plus at least one wheezing epi-
sode in the last 12 months. Moreover, subjects with current 
asthma were asked if at least one visit to the hospital emergency 
department because of an asthma exacerbation had occurred.
Rhinitis-related impact on QoL was considered if the answer 
to the question “In the last 12 months, how much did nasal 
symptoms interfere with your daily activities? ” was “moderately/
highly ”.
Information on possible confounders or effect modifiers was 
also collected. Domestic mold/dampness exposure was evalu-
ated based on the question: “Have you ever seen mold/damp-
ness/fungi on the walls or on the ceiling of your bedroom? ” Envi-
ronmental tobacco smoke (ETS) exposure was assessed based 
on the question “Are there smokers at home?” Self reported 
traffic exposure was recorded as the frequency of trucks pass-
ing on a residential street on weekdays (never/rare/frequent/
constant) and subjects were considered exposed if they an-
swered “frequent ” or “constant.”
Parental history for atopy was defined as at least one parent 
with a personal history of allergic respiratory diseases (asthma 
and/or rhinitis). Household crowding index (HCI) was defined 
as the total number of co-residents per household, excluding 
newborn infants, divided by the total number of rooms, exclud-
ing the kitchen and bathrooms. HCI was dichotomized at the 
level of its 50th percentile (< 1.0 and ≥ 1.0) and used as an in-
dex of socioeconomic status.12
Height and weight were measured in all children in standing 
position without shoes using a stadiometer and an electronic 
digital scale: body mass index (BMI) was computed as weight/
height2 (kg/m2). Overweight-obese children were defined fol-
lowing the gender- and age-specific BMI cut-offs by Cole.13
SPT
SPTs were performed following EAACI recommendations14 
with a panel including 8 common aeroallergens, as well as pos-
itive and negative controls (Stallergènes Italia S.r.l., Milan, Italy). 
Allergic sensitization was defined as the presence of at least one 
positive skin prick test. Atopic index (AI) was computed as the 
number of the individual positive SPT and classified as follows: 
0, no allergic sensitization; 1, 1 positive SPT; 2, 2 positive SPTs; 
and 3, 3 or more positive SPTs. Allergens were grouped in pe-
rennial (Parietaria judaica, Dermatophagoides, dog and cat 
dander, Blattella germanica, and alternaria) and seasonal 
(grass mix and olive).
Data analyses
Frequency distribution of variables was evaluated using the χ2 
test. To identify independent variables that influence the risk 
for a dependent variable, adjusting for confounders, logistic re-
gression models were used and odds ratios (OR) with corre-
sponding 95% confidence intervals (CI) were calculated for all 
predictors.
Computations were performed using the StatView statistical 
software package (SAS Institute, Cary, NC, USA). A probability 
Table 1. General sample characteristics
Overall Males Females
Gender (No., %) 2,150 1,057 (49.2) 1,093 (50.8)
Age (mean±SD) 12.59 (±1.04) 12.60 (±1.05) 12.59 (±1.03)
Height, cm (mean±SD) 154.2 (±8.4) 154.9 (±9.4) 153.5 (±7.2)
Weight, kg (mean±SD) 51.0 (±13.0) 51.9 (±13.7) 50.1 (±12.3)
Body Mass Index, kg/m2   
  (mean±SD)
21.3 (±4.3) 21.4 (±4.4) 21.1 (±4.3)
Subjects with positive skin  
  prick tests (No., %)
842 (39.2) 476 (45.0) 366 (33.5)*
   Subjects with 1 positive  
      SPT (No., %)
372 (17.3) 200 (18.9) 173 (15.8)*
   Subjects with 2 positive 
     SPTs (No., %)
217 (10.1) 128 (12.1) 89 (8.1)*
   Subjects with ≥3 positive 
     SPTs (No., %)
253 (11.8) 148 (14.0) 104 (9.6)*
Exposure to environmental
  tobacco smoke (No., %)
1,216 (56.6) 589 (55.7) 627 (57.4)
Exposure to traffic† in the
  zone of residence (No., %)
453 (21.1) 211 (20.0) 242 (22.1)
Mold/dampness exposure   
  (No., %)
322 (15.0) 147 (13.9) 175 (16.0)
*P< 0.0001, χ2 test.
†(frequent or constant).
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level <0.05 was considered to indicate significance.
 
RESULTS
Sample characteristics (2,150 subjects: M 49.2 %) are shown 
in Table 1. Excluding asthma, no chronic pulmonary disease 
was reported; none of the children were active smokers. The 
prevalence of allergic sensitization was 39.2% (45.0% in males 
and 33.5% in females, P < 0.0001, χ2 test).
In the overall sample, we found a prevalence of 18.2% (391/ 
2,150) for rhinitis (17.3% alone and 0.9% in association with 
CA) and of 20.5% (440/2,150) for rhinoconjunctivitis (18.3% 
alone and 2.2% in association with CA) (Table 2). The preva-
lence rate of CA was 4.2% (90/2,150). Because CA was strongly 
associated with rhinitis (74.4% of subjects with CA had rhinitis 
or rhinoconjunctivitis), to evaluate factors influencing the prev-
alence of rhinitis and rhinoconjunctivitis we excluded subjects 
with CA from the analyses. On the remaining 2,060 subjects, 
the proportion of rhinitis was 37.1%; 18.0% isolated and 19.1% 
in association with conjunctivitis.
There were fewer females than males among subjects without 
Table 2. Frequency distribution of subjects without rhinitis or rhinoconjunctivi-
tis, subjects with rhinitis, and subjects with rhinoconjunctivitis with respect to 
the presence/absence of current asthma
Current asthma
No        Yes Total sample
No rhinitis, no  
  rhinoconjunctivitis (N, %)
1,296 (60.3) 23 (1.1) 1,319 (61.3)
Rhinitis (N, %) 371 (17.3) 20 (0.9) 391 (18.2)
Rhinoconjunctivitis (N, %) 393 (18.3) 47 (2.2) 440 (20.5)
Total sample (N, %) 2,060 (95.8) 90 (4.2) 2,150 (100)
Table 3. Effect of personal and environmental characteristics on the preva-
lence of rhinitis and rhinoconjunctivitis
No rhinitis, no
rhinoconjunctivitis Rhinitis Rhinoconjunctivitis P value*
Gender  
  (No., M/F)
655/641 192/179 160/233 0.0014
Parental  
  history for  
  atopy (%)
13.8 17.0 24.4 <0.0001
Mold/ 
  dampness (%)
12.8 15.6 19.6 0.003
Exposure to  
  environmental  
  tobacco smoke 
  (%)
53.2 60.6 62.3 0.001
Reported  
  exposure to   
  truck traffic (%)
18.7 21.0 25.7 0.01
*χ2 test.
Table 4. Frequency distribution of subjects without rhinitis  or rhinoconjunctivi-
tis, subjects with rhinitis, and subjects with rhinoconjunctivitis for each class of 
Atopic Index (0-no allergic sensitizations, 1-one positive skin test, 2-two posi-
tive skin tests, 3-three or more positive skin tests). Differences were significant 
(P <0.0001, χ2 test)
Atopic index No rhinitis, no  rhinoconjunctivitis Rhinitis Rhinoconjunctivitis
Class 0 (%) 66.3 16.6 17.1
Class 1 (%) 61.7 20.4 17.9
Class 2 (%) 57.8 19.1 23.1
Class 3 (%) 49.8 22.0 28.2
Table 5. Multiple logistic regression analysis of determinants for having con-
junctivitis associated with rhinitis. Data are expressed as odds ratios (OR) and 
95% confidence intervals (95% CI)
OR 95% CI P value
Female gender (ref. male) 1.42 1.14-1.79 0.002
Household crowding index (reference: <1) 1.27 0.99-1.56 0.054
Parental history for atopy  
  (reference no history)
2.01 1.53-2.65 <0.0001
Heavy traffic (ref. “never/rare”) 1.57 1.21-2.03 0.0006
Mold/dampness (reference no exposure) 1.56 1.17-2.10 0.003
Exposure to environmental tobacco smoke   
  (ref. no exposure)
1.53 1.22-1.93 0.0003
Allergen sensitization*
  Sensitization to seasonal allergens  
     (ref. no sensitization)
0.95 0.4-1.96 0.90
  Sensitization to perennial allergens  
     (ref. no sensitization)
1.44 1.10-1.89 0.009
  Sensitization to seasonal+perennial  
    allergens (ref. no sensitization)
2.33 1.71-3.17 <0.0001
*P for trend <0.0001.
rhinitis or rhinoconjunctivitis (49.5%) and those with rhinitis 
(48.2%), while there were more females than males with rhino-
conjunctivitis (59.3%, P=0.0014, χ2 test). Similarly, parental his-
tory for atopy, domestic exposure to mold/dampness, ETS, and 
reported truck traffic in the residential streets were more fre-
quent in rhinoconjunctivitis (Table 3). Rhinoconjunctivitis was 
significantly more frequent in those with higher AI than rhinitis 
(Table 4). In a multiple logistic regression model, high truck 
traffic, mold/dampness, and ETS were independent risk factors 
for the association of conjunctivitis with rhinitis (Table 5). In the 
same model, sensitization to perennial allergens and to peren-
nial plus seasonal allergens increased the risk of having con-
junctivitis, while isolated sensitization to seasonal allergens did 
not increase the risk for conjunctivitis.
In the overall samples (N=2,150), the prevalence of current 
asthma was 1.7% among subjects without rhinitis or rhinocon-
junctivitis, 5.1% among those with rhinitis, and 10.7% among 
those with rhinoconjunctivitis (P<0.0001, χ2 test). Among sub-
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jects with current asthma, 15.6% reported a hospitalization due 
to asthma exacerbation in the last 12 months. In a multiple lo-
gistic regression model, rhinoconjunctivitis produced a twofold 
independent risk for current asthma with respect to rhinitis 
alone, which was larger than the risk produced by allergic sen-
sitization, parental history for asthma, and heavy traffic (Table 
6). Consequently, combinations of allergic sensitization, rhini-
tis, and rhinoconjunctivitis strongly increased the frequency of 
current asthma, as shown in Table 7. Hospitalization for asth-
ma exacerbation was reported in 0.5% of children without rhi-
nitis or rhinoconjunctivitis, 1.3% in rhinitis, and 2.0% in rhino-
conjunctivitis (P=0.008, χ2 test).
Subjects with rhinoconjunctivitis had poorer QoL; children 
referring “moderate/high” impact of rhinitis alone on daily ac-
tivities were 4.6% compared to 10.7% of subjects with rhinocon-
junctivitis (P=0.002, χ2 test). In a logistic model, when correct-
ing for confounders, having conjunctivitis doubled the risk of 
“moderate/high” impact on QoL (Table 8).
DISCUSSION
In this cross-sectional evaluation, we identified an elevated 
prevalence of rhinitis and rhinoconjunctivitis among adoles-
cents. The association of conjunctivitis with rhinitis (i.e., rhino-
conjunctivitis) was more frequent in subjects with multiple al-
lergic sensitizations and those exposed to environmental risk 
factors. The association of conjunctivitis with rhinitis strongly 
increased the risk for current asthma and had a significant im-
pact on QoL.
Respiratory symptoms were investigated using the well-vali-
dated questionnaire-based definitions of the ISAAC Study.11 
The core questions on rhinitis were highly specific, even though 
they showed a lower sensitivity for detecting atopy in a general 
population of children15. To address this issue, individual aller-
gic sensitization was objectively evaluated using SPT. In our 
population sample, the prevalence of rhinitis (not associated 
with conjunctivitis) was 18.2%, while rhinoconjunctivitis preva-
lence was 20.5%; i.e., 38.7% of subjects had rhinitis in the last 12 
months with or without conjunctivitis, and conjunctivitis was 
present in 52.9% of children with rhinitis. These results are 
comparable to those found in 2002 in Italian metropolitan ar-
eas following the same rhinitis and rhinoconjunctivitis defini-
tions; conjunctivitis was reported in 56.6% of children with rhi-
nitis.8 A survey conducted on 396 Swedish schoolchildren 
showed a prevalence of 17.6% for rhinoconjunctivitis and ob-
served a comorbidity between rhinitis and conjunctivitis of 
~92%.16 According to the ISAAC-phase III study, the prevalence 
of nasal symptoms associated with itchy/watery eyes ranged 
from 2.2%-24.2% in children and 4.5%-45.1% in adolescents.3 
Determination of the prevalence of conjunctivitis by alone was 
not possible in the present study; in fact, the adopted question-
naire evaluated conjunctivitis only as a comorbidity of rhinitis.11 
This did not allow the assessment of individuals possibly hav-
Table 6. Multiple logistic regression analysis of determinants for current asthma. 
Data are expressed as odds ratios (OR) and 95% confidence intervals (95% CI)
OR 95% CI P value
Gender (reference: female) 1.36 0.86-2.16 0.19
Heavy traffic (reference: “never/rare”) 1.74 1.08-2.80 0.024
Mold/dampness (reference no exposure) 1.65 0.96-2.83 0.72
Exposure to environmental tobacco smoke  
  (ref. no exposure)
1.40 0.87-2.24 0.17
Parental history for atopy  
  (reference no history)
4.92 2.97-8.16 <0.0001
Household crowding index (reference: <1) 0.67 0.42-1.06 0.088
Atopic index*
  AI=1 (reference: AI=0) 3.29 1.79-6.05 0.0001
  AI=2 (reference: AI=0) 3.66 1.86-7.17 0.0002
  AI=3 (reference: AI=0) 4.45 2.42-8.16 <0.0001
Rhinitis  
  (ref.: neither rhinitis nor rhinoconjunctivitis)*
2.28 1.21-4.30 0.010
Rhinoconjunctivitis  
  (ref.: neither rhinitis nor rhinoconjunctivitis)*
5.23 3.06-8.96 <0.0001
*P for trend <0.0001.
Table 7. Effects of different combinations of allergic sensitization and disease 
status (presence of rhinitis/rhinoconjunctivitis) on current asthma prevalence
Disease  
status
Allergic  
sensitization
Frequency distribution of  
different combination 
between disease status 
and allergic sensitization (%)
Prevalence 
of current  
asthma (%)
No rhinitis, no  
  rhinoconjunctivitis
No 41.4 0.7
Rhinitis No 10.3 3.2
Rhinoconjunctivitis No 10.7 4.8
No rhinitis, No  
  rhinoconjunctivitis
Yes 21.5 3.7
Rhinitis Yes 7.7 7.6
Rhinoconjunctivitis Yes 8.4 17.3
Table 8. Multiple logistic regression analysis for “moderate/high” rhinitis-re-
lated impact on quality of life. Data are expressed as odds ratios (OR) and 95% 
confidence intervals (95%CI)
OR 95% CI P value
Gender (reference: female) 1.59 0.95-2.65 0.080
Household crowding index (reference: <1) 1.32 0.76-2.29 0.33
Overweight-obesity* (ref.: normal weight) 1.75 0.92-3.33 0.087
Allergic sensitization (reference: none) 0.84 0.50-1.41 0.51
Current asthma (ref.: no current asthma) 2.64 1.31-5.32 0.007
Rhinoconjunctivitis (ref.: rhinitis) 2.08 1.19-3.62 0.010
*Overweight-obese children were defined following the gender- and age-spe-
cific cut-off points by Cole et al.13
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ing conjunctivitis without symptoms of rhinitis.
By analyzing risk factors for the association between rhinitis 
and rhinoconjunctivitis, we excluded subjects with current 
asthma, which was more frequent in rhinitis and rhinoconjunc-
tivitis. Since current asthma was strongly associated with rhini-
tis, the exclusion of current asthma from the analysis allowed 
better evaluation of the factors influencing the prevalence of 
rhinitis and rhinoconjunctivitis,  in so far as asthma is linked to 
somewhat different risk factors than rhinitis.8 As reported in 
previous studies,17 rhinoconjunctivitis was associated with an 
increased frequency of parental history of atopy with respect to 
rhinitis, suggesting that a family history of allergic disease rep-
resents a risk factor for rhinoconjunctivitis in children. Similar-
ly, rhinoconjunctivitis was associated with a higher level of al-
lergic sensitization (i.e., higher AI) than rhinitis. After allergen 
stratification, sensitization to perennial allergens yielded an in-
creased risk for rhinoconjunctivitis; a further increase was ob-
served in subjects sensitized to both perennial and seasonal al-
lergens. Conversely, sensitization to seasonal allergens resulted 
in no increase in conjunctivitis with respect to non-sensitized 
individuals. These observations are in line with the study of 
Weinmayr et al., suggesting that atopy is an important risk fac-
tor for rhinoconjunctivitis but only marginally relevant for rhi-
nitis without conjunctivitis.18 Similarly, in a recent survey con-
ducted in Norway, children with rhinitis and sensitization to at 
least one inhalant allergen had more frequent conjunctivitis 
than children with rhinitis without sensitization.19 Conversely, 
in a recent report on 9-11-year-old Turkish schoolchildren, ato-
py was not shown as a risk factor for rhinoconjunctivitis in chil-
dren17, and Canonica et al. reported that ocular symptoms were 
more common in subjects with seasonal and seasonal plus pe-
rennial rhinitis than in those with perennial rhinitis.20
The ISAAC questionnaire also provided information on possi-
ble confounding factors and effect modifiers. In particular, self-
reported exposure to traffic could be affected by reporting bias 
altering the association between reported exposure to road traf-
fic and disease.21 Nevertheless, Nuvolone et al. demonstrated 
that a strong relationship exists between self-reported exposure 
to vehicular traffic and residential proximity to main roads, as 
evaluated using the Geographical Information System technol-
ogy.22 In our bivariate models, conjunctivitis was significantly 
associated with rhinitis among subjects exposed to mold/
dampness, ETS, and truck traffic. In a multiple logistic model, 
these variables were independent risk factors for having con-
junctivitis associated with rhinitis. As shown previously,8,17 these 
results emphasize the role of “preventable/modifiable” factors 
on rhinoconjunctivitis. Mold exposure or sensitization was as-
sociated with rhinitis in clinical observations and epidemiolog-
ical surveys,23 in particular during the first year of life.17
Studies examining the association between passive smoking 
and rhinoconjunctivitis are conflicting. Mitchell et al. found a 
weak association between ETS and symptoms of rhinocon-
junctivitis, concluding that the relationship may not be causal.24 
One study reported a reduced risk of rhinoconjunctivitis for 
children exposed to parental smoking.25 Conversely, Gonzalez-
Diaz et al. showed that passive smoking is one of the risk factors 
for both rhinitis and rhinoconjunctivitis.26 More recently, we 
found that ETS is a significant risk factor for rhinoconjunctivi-
tis.8 Similarly, a study by Montefort et al. reported that smoking 
by the mother alone was more common in children having cur-
rent rhinitis, while smoking by the mother and/or father led to 
rhinoconjunctivitis.27
We also found that an increased frequency of high reported 
truck traffic in the residential streets was an independent risk 
factor for the association between rhinitis and conjunctivitis 
(OR 1.57). Although evidence exists that allergic respiratory dis-
orders are associated with traffic exposure in children, the find-
ings are not consistent. Many studies have found an association 
between traffic exposure and atopic sensitization,28-30 and there 
is experimental evidence that diesel particles may enhance al-
lergic sensitization to common inhalant allergens.31 In agree-
ment with these findings, an association was found between in-
creased exposure to self-reported truck traffic on the residential 
streets and childhood symptoms of rhinoconjunctivitis.32 Simi-
larly, Zuraimi et al. reported a correlation between self-report-
ed traffic density and rhinoconjunctivitis.33 Conversely, a recent 
study found little or no association between ambient particu-
late pollution and the global rhinoconjunctivitis prevalence.34
Epidemiological and clinical data from many studies showed 
a significant association between rhinitis and asthma, support-
ing the hypothesis that rhinitis is a risk factor for asthma.4 Chil-
dren with allergic rhinitis and asthma require a larger amount 
of medication than children with asthma alone, corroborating 
the hypothesis that the association between rhinitis and cur-
rent asthma is characterized by increased disease severity.35 In 
the overall population sample, we found that rhinoconjunctivi-
tis was more strongly associated with current asthma than rhi-
nitis alone. In addition, using a logistics model, the presence of 
conjunctivitis significantly increased the risk for current asthma 
with respect to rhinitis independently of allergic sensitization. 
In sensitized children with rhinoconjunctivitis, the prevalence 
of current asthma increased to 17.3%; i.e., more than fourfold 
the current asthma prevalence in the overall sample (4.2%). Fi-
nally, rhinoconjunctivitis was associated with an increased 
number of visits to the hospital emergency department for 
asthma exacerbation, suggesting that the presence of conjunc-
tivitis may be coupled with more severe disease. These results 
highlight the importance of conjunctivitis as an independent 
risk factor for asthma, supporting the link between upper and 
lower respiratory tracts (united airway disease). In this context, 
conjunctivitis should be considered part of this entity because 
the allergic inflammatory response involves the conjunctiva as 
well as the respiratory tract.3 In agreement with our results, re-
cent studies have highlighted the significance of ocular symp-
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toms, but few studies have explored the impact of allergic con-
junctivitis as a comorbidity of asthma.3
Concerning the impact of rhinoconjunctivitis on QoL, we 
found that adolescents with rhinoconjunctivitis had significant-
ly poorer QoL; in fact, 4.6% of subjects reported a high/moder-
ate impact of rhinitis while 10.7% reported a high impact of rhi-
noconjunctivitis. Rhinoconjunctivitis is known to have an im-
portant impact on QoL, social interactions, and productivity 
both in children17 and adults.36 Ocular symptoms associated 
with allergic rhinitis, often under-diagnosed and under-treated, 
are increasingly recognized as a distinct disorder that imposes 
its own burden on medical costs and patient’s QoL, especially in 
those with persistent moderate/severe nose symptoms.4 Ap-
proximately 50% of patients with rhinitis stated that ocular 
symptoms were moderately to extremely bothersome in the re-
cent “Allergies in America” survey, and 10% of those complained 
that red/itching eyes were the most annoying symptom.37
In conclusion, our study investigated the impact of conjuncti-
vitis on rhinitis and current asthma, as well as the risk factors 
and burden of rhinoconjunctivitis in schoolchildren. We found 
that atopic parental history, allergic sensitization, and environ-
mental factors such as exposure to mold/dampness, ETS and 
heavy traffic are important risk factors for rhinoconjunctivitis. 
We also found that rhinoconjunctivitis is more strongly associ-
ated with current asthma than rhinitis and that the presence of 
conjunctivitis increases the risk for current asthma with respect 
to rhinitis alone. Finally, the presence of conjunctivitis may sig-
nificantly worsen the QoL in patients with rhinitis. Since aller-
gic ocular symptoms are often underdiagnosed and under-
treated, clinicians should investigate these disorders and the 
risk factors within routine clinical practice to reduce the burden 
of disease in allergic patients, improving their QoL.
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